Innovex Completes Divestment of Subsea Tree Product Line
Divestment Announcement: Innovex International has completed the sale of its Subsea Tree product line to Trendsetter Engineering in an all-cash deal, allowing Innovex to focus on its core subsea products and improve shareholder returns.
Strategic Growth for Trendsetter: The acquisition enhances Trendsetter's portfolio by adding subsea tree solutions, enabling them to expand their market reach and better serve customers in the subsea production sector.
Get Free Real-Time Notifications for Any Stock
Analyst Views on INVX
About INVX
About the author
Tesla Set to Surge by 26%? Check Out 10 Leading Analyst Predictions for Monday
Analyst Upgrades: Keefe, Bruyette & Woods upgraded Blackstone Mortgage Trust from Market Perform to Outperform, raising its price target from $20 to $21, while TD Cowen upgraded Yum! Brands from Hold to Buy with a new target of $173.
Analyst Downgrades: Morgan Stanley downgraded HP Inc. from Equal-Weight to Underweight, lowering its price target from $26 to $24, and also downgraded Dell Technologies from Overweight to Underweight with a target cut from $144 to $110.
Price Target Increases: Mizuho raised Snowflake Inc.'s price target from $260 to $285 while maintaining an Outperform rating, and Roth Capital increased Canadian Solar Inc.'s target from $11 to $30, keeping a Neutral rating.
Mixed Ratings: Stifel raised Tesla's price target from $483 to $508 while maintaining a Buy rating, but downgraded Sealed Air Corporation from Buy to Hold despite increasing its target from $43.8 to $45.
Nvidia Set for Potential 18% Surge? Check Out 10 Leading Analyst Predictions for Friday
Analyst Upgrades: Susquehanna raised the price target for Nu Holdings from $17 to $19, while Loop Capital upgraded Shake Shack from Hold to Buy, increasing its target from $98 to $127.
Analyst Downgrades: Stifel cut Lowe’s price target from $275 to $230, and Mizuho reduced Applied Materials' target from $215 to $205, maintaining Neutral and Hold ratings respectively.
Mixed Ratings: Oppenheimer raised ORIC Pharmaceuticals' target from $12 to $15 with an Outperform rating, while HC Wainwright cut Sanara Medtech's target from $54 to $36 but maintained a Buy rating.
Other Notable Changes: Morgan Stanley increased NVIDIA's target from $210 to $220, and Jefferies raised Gap Inc's target from $22 to $30, upgrading it from Hold to Buy.
